Literature DB >> 16912305

All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Sadayuki Ohkura1, Melvyn W Yap, Tom Sheldon, Jonathan P Stoye.   

Abstract

Recent studies have revealed the contribution of TRIM5alpha to retrovirus restriction in cells from a variety of primate species. TRIM5alpha consists of a tripartite motif (the RBCC domain) followed by a B30.2 domain. The B30.2 domain is thought to be involved in determination of restriction specificity and contains three variable regions. To investigate the relationship between the phylogeny of primate TRIM5alpha and retrovirus restriction specificity, a series of chimeric TRIM5alpha consisting of the human RBCC domain followed by the B30.2 domain from various primates was constructed. These constructs showed restriction profiles largely consistent with the origin of the B30.2 domain. Restriction specificity was further investigated with a variety of TRIM5alphas containing mixed or mutated B30.2 domains. This study revealed the importance of all three variable regions for determining restriction specificity. Based on the molecular structures of other PRYSPRY domains solved recently, a model for the molecular structure of the B30.2 domain of TRIM5alpha was developed. The model revealed that the variable regions of the B30.2 domain are present as loops located on one side of the B30.2 core structure. It is hypothesized that these three loops form a binding surface for virus and that evolutionary changes in any one of the loops can alter restriction specificity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912305      PMCID: PMC1563890          DOI: 10.1128/JVI.00688-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Use of a transient assay for studying the genetic determinants of Fv1 restriction.

Authors:  M Bock; K N Bishop; G Towers; J P Stoye
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  A conserved mechanism of retrovirus restriction in mammals.

Authors:  G Towers; M Bock; S Martin; Y Takeuchi; J P Stoye; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Structural and functional insights into the B30.2/SPRY domain.

Authors:  Jae-Sung Woo; Joon-Hyuk Imm; Chang-Ki Min; Kyung-Jin Kim; Sun-Shin Cha; Byung-Ha Oh
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

4.  Papio cynocephalus endogenous retrovirus among old world monkeys: evidence for coevolution and ancient cross-species transmissions.

Authors:  R Mang; J Maas; A C van Der Kuyl; J Goudsmit
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Isolation and phylogeny of endogenous retrovirus sequences belonging to the HERV-W family in primates.

Authors:  Heui-Soo Kim; Osamu Takenaka; Timothy J Crow
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

6.  Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates.

Authors:  C Voisset; A Blancher; H Perron; B Mandrand; F Mallet; G Paranhos-Baccalà
Journal:  AIDS Res Hum Retroviruses       Date:  1999-11-20       Impact factor: 2.205

7.  Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.

Authors:  D Nègre; P E Mangeot; G Duisit; S Blanchard; P O Vidalain; P Leissner; A J Winter; C Rabourdin-Combe; M Mehtali; P Moullier; J L Darlix; F L Cosset
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

8.  Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.

Authors:  T Schnell; P Foley; M Wirth; J Münch; K Uberla
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

9.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

10.  Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.

Authors:  Melvyn W Yap; Mark P Dodding; Jonathan P Stoye
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more
  96 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

3.  The retroviral restriction factor TRIM5alpha.

Authors:  Sarah Sebastian; Jeremy Luban
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

4.  An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.

Authors:  Sarah Sebastian; Christian Grütter; Caterina Strambio de Castillia; Thomas Pertel; Silvia Olivari; Markus G Grütter; Jeremy Luban
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

Review 5.  The structural biology of HIV assembly.

Authors:  Barbie K Ganser-Pornillos; Mark Yeager; Wesley I Sundquist
Journal:  Curr Opin Struct Biol       Date:  2008-04-09       Impact factor: 6.809

Review 6.  Studies of endogenous retroviruses reveal a continuing evolutionary saga.

Authors:  Jonathan P Stoye
Journal:  Nat Rev Microbiol       Date:  2012-05-08       Impact factor: 60.633

Review 7.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

8.  A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.

Authors:  Haihan Song; Emi E Nakayama; Masaru Yokoyama; Hironori Sato; Jay A Levy; Tatsuo Shioda
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis.

Authors:  Greg Brennan; Yury Kozyrev; Shiu-Lok Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

10.  Independent evolution of an antiviral TRIMCyp in rhesus macaques.

Authors:  Sam J Wilson; Benjamin L J Webb; Laura M J Ylinen; Ernst Verschoor; Jonathan L Heeney; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.